Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 2.1B | 1.9B | 2.1B | 1.8B |
Cost of revenue | 707.2M | 684.5M | 663.5M | 571.3M |
Gross profit | 1.4B | 1.3B | 1.4B | 1.2B |
Operating expense | ||||
Research & development | 269.5M | 272.0M | 253.5M | 246.0M |
Selling general and admin | 482.7M | 484.6M | 527.0M | 439.2M |
Other operating expenses | — | — | — | — |
Operating income | 639.5M | 497.3M | 632.2M | 496.6M |
Non operating interest income | ||||
Income | 76.3M | 77.8M | 64.4M | 80.6M |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 715.8M | 575.0M | 696.6M | 577.2M |
Tax provision | 144.4M | -30.3M | 104.8M | 86.4M |
Net income | 571.3M | 605.3M | 591.8M | 490.8M |
Basic EPS | 1.8 | 2.0 | 1.9 | 1.6 |
Diluted EPS | 1.8 | 1.9 | 1.9 | 1.6 |
Basic average shares | 308.4M | 307.5M | 306.6M | 306.1M |
Diluted average shares | 313.2M | 313.6M | 313.0M | 312.0M |
EBITDA | 773.1M | 618.5M | 739.4M | 596.5M |
Net income from continuing op. | 571.3M | 605.3M | 591.8M | 490.8M |
Minority interests | -5.0M | -4.6M | -2.0M | -4.7M |
Preferred stock dividends | — | — | — | — |